Evaluating DOAC dipstick testing in the management of acute stroke: protocol for a multicentre, prospective, observational registry study
Introduction Direct oral anticoagulants (DOACs) are preferred over vitamin K antagonists for stroke prophylaxis in non-valvular atrial fibrillation. Yet, DOAC use is regarded as a contraindication for intravenous thrombolysis in acute ischaemic stroke. The stratification of patients into ‘on-therapy...
Saved in:
| Main Authors: | Philip Choi, Helen Dewey, Edward Patrick Callaly, Peter Shuangyue Tan, Emily Schembri, Marija Borosak |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-06-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/15/6/e102092.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Influence of DOACS and DOAC-REMOVE® on coagulation assays during thrombophilia testing in DOAC-treated patients
by: Kovač Mirjana, et al.
Published: (2022-01-01) -
Clinical impact of inappropriate DOAC dosing in atrial fibrillation: Insights from a real-world registry
by: Mustafa Yildirim, et al.
Published: (2025-02-01) -
Direct oral anticoagulants (DOACs): From the laboratory point of view
by: Margetić Sandra, et al.
Published: (2022-12-01) -
Dipstick Urinalysis Screening of Healthy Neonates
by: Behnaz Falakaflaki, et al.
Published: (2011-06-01) -
PO93 | Use of DOACS in heart transplantation recipients
Published: (2025-08-01)